Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Role of the FDA

Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Role of the FDA

by Peter R. Breggin

Paperback

$42.76 $48.95 Save 13% Current price is $42.76, Original price is $48.95. You Save 13%.
View All Available Formats & Editions

Temporarily Out of Stock Online

Eligible for FREE SHIPPING

Overview

Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Role of the FDA by Peter R. Breggin

"In this book, renowned psychiatrist Peter Breggin documents how psychiatric drugs and electroshock disable the brain. He presents the latest scientific information on potential brain dysfunction and dangerous behavioral abnormalities produced by the most widely used drugs, including Prozac, Xanax, Halcion, Ritalin, and lithium."

Product Details

ISBN-13: 9780826194916
Publisher: Springer Publishing Company
Publication date: 01/01/2004
Pages: 316
Product dimensions: 5.80(w) x 8.90(h) x 0.70(d)

About the Author

Peter R. Breggin, MD, is a Harvard-trained psychiatrist and former full-time consultant at NIMH. He is in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books. Some of his many books include Toxic Psychiatry, Talking Back to Ritalin, The Antidepressant Fact Book, and The Heart of Being Helpful: Empathy and the Creation of a Healing Presence, and, with co-author Ginger Breggin, Talking Back to Prozac. His most recent publications include Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide, and Crime (2008) and Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock and the Psychopharmaceutical Complex, Second Edition (SPC, 2008). Dr. Breggin is the founder and director of The Center for the Study of Empathic Therapy, Education and Living (www.EmpathicTherapy.org) His professional website is www.breggin.com.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews